IN THE NEWS: Genomic health literacy in treatment decision-making for prostate cancer

Uro Today

Elisabeth Heath, M.D., FACP, medical oncologist, leader of the Genitourinary Oncology Multidisciplinary Team (MDT) and member of the Phase 1 Clinical Trials MDT, discusses ways providers can explain genetic and genomic testing to prostate cancer patients. 

Watch the discussion here.